Paclitaxel–ifosfamide–carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours

BACKGROUND: Malignant mixed Mullerian tumours (MMMTs) of the uterus and adnexa represent aggressive gynaecologic malignancies with a high rate of loco-regional and distant failure. For that reason, we evaluated the paclitaxel–ifosfamide–carboplatin (TICb) combination in patients with advanced MMMTs....

Descripción completa

Detalles Bibliográficos
Autores principales: Kosmas, C, Vorgias, G, Tsakonas, G, Politis, P, Daladimos, T, Panagiotidi, E, Papachrysanthou, T, Moschovis, D, Kalinoglou, N, Tsavaris, N, Karabelis, A, Mylonakis, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185936/
https://www.ncbi.nlm.nih.gov/pubmed/21847127
http://dx.doi.org/10.1038/bjc.2011.316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185936/
https://www.ncbi.nlm.nih.gov/pubmed/21847127
http://dx.doi.org/10.1038/bjc.2011.316

Ejemplares similares